MSL3
Overview
MSL3 encodes a component of the male-specific lethal (MSL) chromatin-modifying complex. It is a newly nominated CLL driver in the integrated CLL map.
Alterations observed in the corpus
- Predominantly clonal novel driver in M-CLL PMID:35927489.
Cancer types (linked)
- CLLSLL — novel M-CLL-enriched driver in the integrated CLL map (n=1,148) PMID:35927489.
Co-occurrence and mutual exclusivity
- None reported.
Therapeutic relevance
- None reported.
Open questions
- Functional validation as a CLL driver is deferred to future work PMID:35927489.
Sources
This page was processed by crosslinker on 2026-04-08.